212 related articles for article (PubMed ID: 32006618)
21. Genetic interaction of hnRNPA2B1 and DNAJB6 in a Drosophila model of multisystem proteinopathy.
Li S; Zhang P; Freibaum BD; Kim NC; Kolaitis RM; Molliex A; Kanagaraj AP; Yabe I; Tanino M; Tanaka S; Sasaki H; Ross ED; Taylor JP; Kim HJ
Hum Mol Genet; 2016 Mar; 25(5):936-50. PubMed ID: 26744327
[TBL] [Abstract][Full Text] [Related]
22. ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells.
Wang JM; Liu BQ; Zhang Q; Hao L; Li C; Yan J; Zhao FY; Qiao HY; Jiang JY; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118647. PubMed ID: 31926942
[TBL] [Abstract][Full Text] [Related]
23. CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.
Zhu W; Jarman KE; Lokman NA; Neubauer HA; Davies LT; Gliddon BL; Taing H; Moretti PAB; Oehler MK; Pitman MR; Pitson SM
Cancer Res; 2017 Sep; 77(18):4823-4834. PubMed ID: 28729416
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.
Srivastava AK; Banerjee A; Cui T; Han C; Cai S; Liu L; Wu D; Cui R; Li Z; Zhang X; Xie G; Selvendiran K; Patnaik S; Karpf AR; Liu J; Cohn DE; Wang QE
Cancer Res; 2019 May; 79(9):2314-2326. PubMed ID: 30894370
[TBL] [Abstract][Full Text] [Related]
25. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X
Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425
[TBL] [Abstract][Full Text] [Related]
26. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
[TBL] [Abstract][Full Text] [Related]
27. Transthyretin affects the proliferation and migration of human retinal microvascular endothelial cells in hyperglycemia via hnRNPA2B1.
Gu Y; Hu D; Xin Y; Shao J
Biochem Biophys Res Commun; 2021 Jun; 557():280-287. PubMed ID: 33894415
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
29. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
[TBL] [Abstract][Full Text] [Related]
30. CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway.
Zhang M; Zhao L
DNA Cell Biol; 2017 Nov; 36(11):983-990. PubMed ID: 28933561
[TBL] [Abstract][Full Text] [Related]
31. RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression.
Fu C; Yuan M; Sun J; Liu G; Zhao X; Chang W; Ma Z
Dis Markers; 2021; 2021():3037337. PubMed ID: 34434291
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 modulates the expression of hnRNPA2B1 and KHSRP.
Santarosa M; Del Col L; Viel A; Bivi N; D'Ambrosio C; Scaloni A; Tell G; Maestro R
Cell Cycle; 2010 Dec; 9(23):4666-73. PubMed ID: 21099359
[TBL] [Abstract][Full Text] [Related]
34. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
[TBL] [Abstract][Full Text] [Related]
35. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
36. Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.
Guo Y; Tian P; Yang C; Liang Z; Li M; Sims M; Lu L; Zhang Z; Li H; Pfeffer LM; Yue J
Pharm Res; 2015 Mar; 32(3):769-78. PubMed ID: 25823356
[TBL] [Abstract][Full Text] [Related]
37. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
39. PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.
Jia Y; Shi H; Cao Y; Feng W; Li M; Li X
Life Sci; 2019 Sep; 233():116715. PubMed ID: 31376371
[TBL] [Abstract][Full Text] [Related]
40. Semaphorin 3A inhibits tumor progression via the downregulation of Lin28B in ovarian cancer.
Ma RY; Yang LN; Chen JN; Chen RJ; Zhang LW; Wang XQ
Neoplasma; 2023 Feb; 70(1):103-113. PubMed ID: 36660796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
